HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kee, C. Articles by Hwang, J.-M. Search for Related Content PubMed PubMed Citation Articles by Kee, C. Articles by Hwang, J.-M.

Stromelysin Gene Transfer into Cultured Human Trabecular Cells and Rat Trabecular Meshwork In Vivo

¹ From the Department of Ophthalmology, Samsung Medical Center, School of Medicine, Sungkyunkwan University, Seoul, Korea; ² Samsung Biomedical Research Institute, Seoul, Korea; and ³ Department of Ophthalmology, Seoul Municipal Boramae Hospital, Seoul National University, College of Medicine, Seoul, Korea.

PURPOSE. To determine whether stromelysin gene can be introduced into and expressed in the cultured human trabecular cells as well as in the rat eye in vivo through means of a recombinant replication-deficient adenovirus.

METHODS. Stromelysin cDNA was obtained by reverse transcription-polymerase chain reaction with mRNA extracted from the cultured human trabecular cells after induction with interleukin 1. Adenovirus vector that contains stromelysin cDNA was constructed by cotransfection of pJM17 and pA.CMV-str into the 293 cells. The expression of stromelysin in the cultured human trabecular cells was assayed by Western blot and zymography. The expression of stromelysin in the trabecular meshwork of the rat eyes was detected by in situ hybridization and immunohistochemistry.

RESULTS. The constructed adenovirus vector contained stromelysin cDNA, but no E1 region. Western blot and zymogram revealed that the stromelysin could be expressed and that it possessed enzymatic activity in cultured human trabecular cells. In situ hybridization and immunostaining of the stromelysin showed that the complete form of stromelysin was expressed in the trabecular meshwork, the iris, and the uveoscleral outflow pathway of the rat eye.

CONCLUSIONS. Stromelysin, a functional gene, can be transferred in vivo into rat eyes and in vitro into cultured human trabecular cells using a replication-deficient adenovirus vector. This shows the possibility of gene therapy in glaucoma.

This article has been cited by other articles:

				P. B. Liton, X. Liu, W. D. Stamer, P. Challa, D. L. Epstein, and P. Gonzalez Specific Targeting of Gene Expression to a Subset of Human Trabecular Meshwork Cells Using the Chitinase 3-Like 1 Promoter Invest. Ophthalmol. Vis. Sci., January 1, 2005; 46(1): 183 - 190. [Abstract] [Full Text] [PDF]

				P. Gonzalez, M. Caballero, P. B. Liton, W. D. Stamer, and D. L. Epstein Expression Analysis of the Matrix GLA Protein and VE-Cadherin Gene Promoters in the Outflow Pathway Invest. Ophthalmol. Vis. Sci., May 1, 2004; 45(5): 1389 - 1395. [Abstract] [Full Text] [PDF]

				S. Sohn, W. Hur, M. K. Joe, J.-H. Kim, Z.-W. Lee, K.-S. Ha, and C. Kee Expression of Wild-Type and Truncated Myocilins in Trabecular Meshwork Cells: Their Subcellular Localizations and Cytotoxicities Invest. Ophthalmol. Vis. Sci., December 1, 2002; 43(12): 3680 - 3685. [Abstract] [Full Text] [PDF]

				T. Borras, C. R. Brandt, R. Nickells, and R. Ritch Gene Therapy for Glaucoma: Treating a Multifaceted, Chronic Disease Invest. Ophthalmol. Vis. Sci., August 1, 2002; 43(8): 2513 - 2518. [Full Text] [PDF]